These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 3332165)
21. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications. Díaz de Heredia C; Moreno A; Olivé T; Iglesias J; Ortega JJ Bone Marrow Transplant; 1999 Jul; 24(2):163-8. PubMed ID: 10455344 [TBL] [Abstract][Full Text] [Related]
22. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen. Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744 [TBL] [Abstract][Full Text] [Related]
24. Opportunistic CNS infection after bone marrow transplantation. Maschke M; Dietrich U; Prumbaum M; Kastrup O; Turowski B; Schaefer UW; Diener HC Bone Marrow Transplant; 1999 Jun; 23(11):1167-76. PubMed ID: 10382957 [TBL] [Abstract][Full Text] [Related]
25. Life-threatening infections occurring more than 3 months after BMT. 18 UK Bone Marrow Transplant Teams. Hoyle C; Goldman JM Bone Marrow Transplant; 1994 Aug; 14(2):247-52. PubMed ID: 7994240 [TBL] [Abstract][Full Text] [Related]
26. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes. Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248 [TBL] [Abstract][Full Text] [Related]
27. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants. Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456 [TBL] [Abstract][Full Text] [Related]
28. Gastroparesis following bone marrow transplantation. Eagle DA; Gian V; Lauwers GY; Manivel JC; Moreb JS; Mastin S; Wingard JR Bone Marrow Transplant; 2001 Jul; 28(1):59-62. PubMed ID: 11498745 [TBL] [Abstract][Full Text] [Related]
30. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [TBL] [Abstract][Full Text] [Related]
31. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation. Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138 [TBL] [Abstract][Full Text] [Related]
32. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect. Soubani AO; Qureshi MA Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117 [TBL] [Abstract][Full Text] [Related]
33. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048 [TBL] [Abstract][Full Text] [Related]
34. Early predictors of transplant-related mortality (TRM) after allogeneic bone marrow transplants (BMT): blood urea nitrogen (BUN) and bilirubin. Bacigalupo A; Oneto R; Bruno B; Soracco M; Lamparelli T; Gualandi F; Occhini D; Raiola A; Mordini N; Berisso G; Bregante S; Dini G; Lombardi A; Lint MV; Brand R Bone Marrow Transplant; 1999 Sep; 24(6):653-9. PubMed ID: 10490732 [TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
36. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. Wald A; Leisenring W; van Burik JA; Bowden RA J Infect Dis; 1997 Jun; 175(6):1459-66. PubMed ID: 9180187 [TBL] [Abstract][Full Text] [Related]
38. [Infections after bone marrow transplantation in childhood]. Ludwig S; Ludwig U; Färber I; Wutzler P; Straube E; Koch H; Hermann J; Fuchs D; Zintl F Kinderarztl Prax; 1992 Jun; 60(4-5):119-23. PubMed ID: 1323001 [TBL] [Abstract][Full Text] [Related]
39. Management of infectious complications of bone marrow transplantation. Wingard JR Oncology (Williston Park); 1990 Feb; 4(2):69-75; discussion 76, 81-2. PubMed ID: 2143670 [TBL] [Abstract][Full Text] [Related]